Table 2.
LFTs and associated laboratory values of patients with liver involvement.
| Variables | n = 104 |
|---|---|
| Elevation of ALT | 85 (81.7) |
| Elevation of AST | 91 (87.5) |
| Elevation of ALP | 53 (51.0) |
| Elevation of GGT | 75 (72.1) |
| Peak ALT (IU/L) | 99 [11, 3436] |
| Peak AST (IU/L) | 87 [16, 3237] |
| Peak ALP (IU/L) | 132.5 [38, 491] |
| Peak GGT (IU/L) | 117 [14, 696] |
| Levels of elevation | |
| Mild (ULN < LFTs ≤ 2 ULN) | 34 (32.7) |
| Moderate (2 ULN < LFTs ≤ 5 ULN) | 32 (30.8) |
| Severe (LFTs > 5 ULN) | 38 (36.5) |
| PreAlb < 180 mg/L | 78 (75.0) |
| Alb < 35 g/L | 88 (84.6) |
| TBil > 24 μmol/L | 6 (5.8) |
| PT > 16 s | 3 (2.9) |
| Hepatomegaly | 18 (17.3) |
Data are presented as median [range] for the peak values of LFTs and as frequency counts (%) for categorical variables. LFTs, liver function tests; ALT, alanine aminotransferase; AST, aspartate aminotransferase; ALP, alkaline phosphatase; GGT, gamma-glutamyl transpeptidase; ULN, upper limits of normal; preAlb, prealbumin; Alb, albumin; TBil, total bilirubin; PT, prothrombin time.